MARKETS PERPS LIVE49

Cash

Trending Elections Politics Culture Sports Crypto Commodities Climate Economics Mentions Finance Tech & Science

Predict Live49 AccountSocial

Product

Kalshi Pro Perpetual Futures Markets Incentive program Institutions API & developers

Company

About Kalshi Research Blog Careers Policy Center Brand Kit

Help

Help Center FAQ Fee schedule Trading hours Regulatory Trust Center

© 2026 Kalshi Inc. · All rights reserved

Privacy Data Terms of Service Trading Prohibitions FAQ for Finance Professionals

Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.

Trending Elections Politics Culture Sports Crypto Commodities Climate Economics Mentions Finance Tech & Science

Eli Lilly

LLY

ReportsAug 7, 2026 · time not confirmed

Fiscal periodNot stated

Market capNot available

Consensus EPSNot covered

Year-ago EPSNot available

Expected changeNot available

Quarterly markets

What will Eli Lilly say during their next earnings call?

Vial
100%
Walmart
100%
Pennsylvania
100%
LillyDirect
100%
Tariff
100%
Nvidia
100%
AI / Artificial Intelligence
100%
Inluriyo
100%
Ventyx
100%
China
100%
Foundayo
100%
Headwind
100%

3 more words trade on this call

Other LLY markets

Trading on company events rather than on this report

Will the FDA approve retatrutide?5 contracts
Will the FDA approve VERVE-102?6 contracts